Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study

June 2008
Current Medical Literature: Gynecology & Obstetrics;2008, Vol. 13 Issue 3, p102
Academic Journal
The article discusses research being done on the impact of cabergoline administration on pregnancy outcome. It references a study by A. Colao and colleagues, published in the 2008 issue of "Clinical Endocrinology." The study examined fetal exposure to cabergoline in several pregnant women. It concluded that cabergoline exposure does not increase the risk of miscarriage or fetal malformation.

Tags: PREGNANCY -- Complications;  PREGNANT women;  DRUGS -- Side effects;  MISCARRIAGE;  FETUS -- Growth


Related Articles

  • Nitrofurantoin.  // Reactions Weekly;2/10/2007, Issue 1138, p20 

    The article presents the case of a 27-year-old pregnant woman who developed acute pneumonitis during treatment with nitrofurantoin. It references an article by A. Mohamed and colleagues in the January 30, 2007 issue of the "Canadian Medical Association Journal." Nitrofurantoin was discontinued...

  • Should I Drop My Antidepressant? Szalavitz, Maia // Psychology Today;Mar/Apr2006, Vol. 39 Issue 2, p59 

    The article focuses on the necessity of taking antidepressants to pregnant women. There are no evidence that antidepressants can affect fetuses and newborns. One of the threats posed by depression to the unborn are miscarriage, premature birth, low birth weight and fetal growth problems. Studies...

  • Fetal Macrosomia in Pregnant Women with Gestational Diabetes. šegregur, Jadranko; Buković, Damir; Milinović, Darko; Orešković, Slavko; Pavelić, Jasminka; Župić, Tomislav; Peršec, Jasminka; Pavić, Mato // Collegium Antropologicum;Dec2009, Vol. 33 Issue 4, p1121 

    The aim of the study was to determine the frequency of fetal macrosomia in newborns from mothers with gestational diabetes mellitus (GDM) and healthy mothers, as well as determining the influence of fetal growth on pregnancy termination, on complications in pregnancy, during delivery and...

  • Guidelines released for pregnant women with asthma.  // Pharmaceutical Representative;Mar2005, Vol. 35 Issue 3, p9 

    Reports on the he National Asthma Education and Prevention Program's issuance of the first guidelines in managing asthma during pregnancy. Report's reflection of medications that have emerged and updated treatment recommendations for pregnant women with asthma based on a systematic review of...

  • Pregnancy after renal transplantation: severe intrauterine growth retardation during treatment with cyclosporin A. Pickrell, M.D.; Sawers, R.; Michael, J. // British Medical Journal (Clinical Research Edition);3/19/1988, Vol. 296 Issue 6625, p825 

    Presents a case study on cyclosporin A treatment during pregnancy after renal transplantation. Safety of cyclosporin during pregnancy; Effect of cyclosporin on fetal growth; Recognition of intrauterine growth retardation as a complication in pregnancy.

  • Psychotropic Medication Use during Pregnancy and Lactation: Role of Ultrasound Assessment. Matthys, Andrew; Ambat, Maria Teresa; Ritsuko Pooh; Plavsic, Sanja Kupesic // Donald School Journal of Ultrasound in Obstetrics & Gynecology;Jan-Mar2014, Vol. 8 Issue 1, p109 

    The potential teratogenic effects of psychotropic medication use during pregnancy have been scrutinized ever since thalidomide contributed to phocomelia in the 1950's. Up to 35% of the half a million women becoming pregnant each day take psychotropic medication(s). Teratogens alter normal...

  • The Significance of Early Pregnancy Units in the Practice of a Busy Obstetric Unit. Abushama, Mandy; Almuhanadi, Halima // Donald School Journal of Ultrasound in Obstetrics & Gynecology;Oct-Dec2012, Vol. 5 Issue 4, p405 

    A significant proportion of women experience bleeding in early pregnancy resulting in considerable distress. Early pregnancy unit (EPAU) should promote the sensitive and efficient management of women with early pregnancy problems and we believe this is best achieved by the establishment of a...

  • Report your own adverse effects. Robinson, Jean // AIMS Journal;2005, Vol. 17 Issue 4, p14 

    The article reports on the need for pregnant women to report the adverse effects of pregnancy medication to the Great Britain Medicines and Healthcare products Regulatory Agency (MHRA). For instance, some oral contraceptives can induce mood changes such as depression. The MHRA assures...

  • Primary Prevention of Congenital Abnormalities Due to High Fever Related Maternal Diseases by Antifever Therapy and Folic Acid Supplementation. Czeizel, Andrew E.; �cs, N�ndor; B�nhidy, Ferenc; Puh�, Erzs�bet H.; Vogt, G�bor // Current Women's Health Reviews;2007, Vol. 3 Issue 3, p190 

    Background: Our previous case-control studies showed an association between high fever related maternal diseases and some congenital abnormalities (CAs). The aim of this review is to summarize the result of these studies completed with available animal and clinical data from the international...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics